Additionally, SF could decrease PD-L1 levels on tumor cells and TAMs by inhibiting the activity of Ras/Raf-MAPK and PI3K-AKT signaling [28], which would rebalance TIME and enhance the therapeutic effect of ICIs. Here, CD274 is linked to neoplasm.